Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients

BACKGROUND: It is hypothesised that cotargeting the androgen receptor (AR) and paracrine androgen biosynthesis with enzalutamide and abiraterone acetate in metastatic castration-resistant prostate cancer (mCRPC) will dissipate adaptive feedback loops observed with either agent alone. OBJECTIVE: To a...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Eur Urol Oncol
Main Authors: Efstathiou, Eleni, Titus, Mark, Wen, Sijin, Troncoso, Patricia, Hoang, Anh, Corn, Paul, Prokhorova, Ina, Araujo, John, Dmuchowski, Carl, Melhem-Bertrandt, Amal, Patil, Shiva, Logothetis, Christopher J.
Format: Artigo
Sprog:Inglês
Udgivet: 2019
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7204265/
https://ncbi.nlm.nih.gov/pubmed/31412017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.euo.2019.01.008
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker